Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway

John Cijiang He1, Ting-Chi Lu, Margaret Fleet

  • 1Department of Medicine, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA. cijiang.he@mssm.edu

Insights

All-trans retinoic acid (atRA) reverses HIV-1 podocyte damage by increasing cAMP levels, restoring differentiation markers and inhibiting proliferation. This treatment also reduced proteinuria and glomerulosclerosis in HIV-1-transgenic mice.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Virology

Background:

  • HIV-associated nephropathy involves renal podocyte proliferation and dedifferentiation.
  • Understanding the molecular mechanisms underlying podocyte dysfunction in HIV-1 infection is crucial.

Purpose of the Study:

  • To investigate the therapeutic potential of all-trans retinoic acid (atRA) in reversing HIV-1-induced podocyte abnormalities.
  • To elucidate the intracellular signaling pathways, particularly cAMP-mediated pathways, involved in atRA's effects on HIV-1-infected podocytes.

Main Methods:

  • Treatment of HIV-1-infected podocytes with atRA and other retinoids.
  • Assessment of cell proliferation, differentiation markers (synaptopodin, nephrin, podocin, WT-1), and intracellular cAMP levels.
  • Pharmacological manipulation using receptor antagonists (RARalpha antagonists), cAMP analogs (forskolin, 8-bromo-cAMP), and pathway inhibitors (Rp-cAMP, rolipram).
  • In vivo studies using HIV-1-transgenic mice to evaluate proteinuria, cell proliferation, and glomerulosclerosis.

Main Results:

  • atRA treatment reduced proliferation and restored differentiation markers in HIV-1-infected podocytes.
  • atRA and 9-cis RA increased intracellular cAMP levels; this effect was RARalpha-dependent.
  • Exogenous cAMP stimulation mimicked atRA's antiproliferative and differentiation-restoring effects.
  • atRA's effects were dependent on the cAMP/protein kinase A pathway and involved suppression of MAPK and Stat3 phosphorylation.
  • In vivo, atRA ameliorated proteinuria, proliferation, and glomerulosclerosis in HIV-1-transgenic mice.

Conclusions:

  • atRA effectively reverses the detrimental effects of HIV-1 on podocytes through a mechanism involving RARalpha-mediated cAMP production.
  • The findings highlight the therapeutic potential of atRA for managing HIV-associated nephropathy.
  • Targeting the cAMP pathway offers a promising strategy for treating HIV-1-induced kidney disease.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...